SpyCloud Launches Supply Chain Solution to Combat Rising Third-Party Identity Threats

New monitoring capability delivers unprecedented visibility into vendor identity exposures, moving enterprises and government agencies from static risk scoring to protecting against actual identity threats. SpyCloud, the leader in identity threat protection, today announced the launch of its Supply Chain Threat Protection solution, an advanced layer of defense that expands identity threat protection across the […]

NanoPass Technologies Expands Product Portfolio to Advance Intradermal Delivery

The Newly Launched MicronJet(TM) 800 Extends the Portfolio into Hair Restoration as well as Thicker Skin Areas and Viscous Substances NanoPass Technologies Ltd., a global leader in intradermal delivery solutions, will officially launch MicronJet(TM) 800 during IMCAS World 2026, taking place January 29 – 31, 2026, in Paris. The launch of MicronJet(TM) 800 expands the

IQST-IQSTEL Issues Shareholder Letter Detailing Artificial Intelligence (AI) Strategy, Commercial Traction, and 2026 Roadmap

New letter outlines IQSTEL’s proprietary AI platform, revenue-generating products, early commercial momentum, and long-term value creation strategy across telecom and technology markets IQSTEL (NASDAQ: IQST), a fast-growing telecom and technology company, today issued a comprehensive Shareholder Letter detailing its Artificial Intelligence strategy, commercial roadmap, and early market traction. The letter provides shareholders with a transparent

Charles Butt Foundation Announces Leadership Transition

The Charles Butt Foundation today announced that Cody Huie will become the organization’s next President, effective January 1, 2026. Huie succeeds Dr. Shari Albright, who has served as President for more than seven years and will become an advisor to the CEO for Fair Winds Management, LLC, the management company for Charles Butt’s philanthropic work.

TrustLogix Introduces TrustAI: The Unified Policy Control Plane for AI Acceleration

TrustAI’s adaptive access controls close the “velocity gap” between AI automation and human-paced governance. Built on the proven TrustAccess and TrustDSPM foundation, TrustAI establishes a unified policy fabric that operates at machine speed, ensuring consistent access decisions across the entire AI and data ecosystem–eliminating the dangerous gap between AI autonomy and traditional access controls. TrustLogix

Lazard to Announce Fourth Quarter and Full Year 2025 Financial Results

Lazard, Inc. (NYSE: LAZ) will announce its fourth quarter and full year 2025 financial results in a press release to be issued Thursday morning, January 29, 2026. The press release will be available in the News & Announcements section of Lazard’s website at www.lazard.com. Lazard will host a conference call at 8:00 a.m. ET on

V-Technologies Announces Acumatica Summit 2026 Sponsorship, Highlighting Acumatica Shipping Software

Discover how StarShip’s multi-carrier shipping automation, showcased at Acumatica Summit, January 25 through 28 in Booth 318, helps Acumatica users reduce manual shipping touchpoints by an average of 40% and streamline operations. As a Silver Sponsor at Acumatica Summit 2026, January 25th through the 28th, V-Technologies will exhibit at Booth #318, where attendees can experience

Bel Fuse Inc. Named One of America’s Most Successful Small-Cap Companies by Forbes

Bel Fuse Inc. (NASDAQ: BELFA) (NASDAQ: BELFB), a leading global manufacturer of products that power, protect, and connect electronic circuits, is proud to announce its inclusion in Forbes’ 2026 list of America’s Most Successful Small-Cap Companies. This prestigious recognition highlights Bel’s strong financial performance, innovation, and strategic growth within the electronics industry. Forbes’ annual ranking

GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma

Westchester Medical Center and Brown University Health are first centers to activate and enroll patients- According to the American Brain Tumor Association, newly diagnosed glioblastoma is one of the most complex tumors to treat with an average patient survival of less than two years- GT Medical Technologies, a company focused on improving the lives of

From Path to Progress: Journal of Independent Medicine Launches 2026 With Its Fifth Issue–Entering Year Two of Conflict-Free, Evidence-Based Science

The Independent Medical Alliance (IMA) today announced the release of Volume 2, Issue 1 of the Journal of Independent Medicine–the journal’s fifth issue to date and the first issue of its second year of publication. Now entering 2026, the Journal continues its mission to publish rigorous, evidence-based, conflict-free science that serves clinicians and patients seeking

Scroll to Top